Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic
Background: The purpose of this study was to characterize the novel sedative/hypnotic agent HSK3486, a 2,6-disubstituted alkylphenol analogue.Methods: The mechanism of action of HSK3486 was studied in competitive binding assays and whole-cell patch clamp assays. HSK3486 was administered by bolus int...
Main Authors: | Juan Liao, Meiting Li, Chaoli Huang, Yan Yu, Yashu Chen, Jiaqi Gan, Jie Xiao, Guilin Xiang, Xizhi Ding, Rong Jiang, Peng Li, Mengchang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.830791/full |
Similar Items
-
The relationship between the effect-site concentration of propofol and sedation scale in children: a pharmacodynamic modeling study
by: Young-Eun Jang, et al.
Published: (2021-09-01) -
Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects
by: Ying Zhou, et al.
Published: (2019-03-01) -
Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment
by: Yue Hu, et al.
Published: (2022-12-01) -
Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01) -
Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly
by: Xiaojiao Li, et al.
Published: (2021-08-01)